These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2753525)

  • 1. Methods of determining sample sizes in clinical trials.
    Jeyaseelan L; Rao PS
    Indian Pediatr; 1989 Feb; 26(2):115-21. PubMed ID: 2753525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biostatistics in clinical trials: Part 2. Determining sample sizes for clinical trials.
    Ellenberg SS
    Oncology (Williston Park); 1989 Aug; 3(8):39-46; discussion 48, 51. PubMed ID: 2519197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The application of the GSK method to the determination of minimum sample sizes.
    Rochon J
    Biometrics; 1989 Mar; 45(1):193-205. PubMed ID: 2655729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple procedures for blinded sample size adjustment that do not affect the type I error rate.
    Kieser M; Friede T
    Stat Med; 2003 Dec; 22(23):3571-81. PubMed ID: 14652861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sample sizes based on the log-rank statistic in complex clinical trials.
    Lakatos E
    Biometrics; 1988 Mar; 44(1):229-41. PubMed ID: 3358991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for one-sided testing of the difference between proportions and sample size considerations related to non-inferiority clinical trials.
    Dann RS; Koch GG
    Pharm Stat; 2008; 7(2):130-41. PubMed ID: 17526060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample sizes in the multivariate analysis of repeated measurements.
    Vonesh EF; Schork MA
    Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group sequential t-test for clinical trials with small sample sizes across stages.
    Shao J; Feng H
    Contemp Clin Trials; 2007 Sep; 28(5):563-71. PubMed ID: 17434814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Roaming through methodology. XXXIII. Ethics of sample size estimation: less subjects needed for a one-sided than for a two-sided statistical investigation].
    Knottnerus JA; Bouter LM
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1051-4. PubMed ID: 11414165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Statistical aspects in planning psychotropic drug trials (author's transl)].
    Ferner U
    Pharmakopsychiatr Neuropsychopharmakol; 1977 May; 10(3):132-9. PubMed ID: 360237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptive, group sequential and decision theoretic approaches to sample size determination.
    Mehta CR; Patel NR
    Stat Med; 2006 Oct; 25(19):3250-69; discussion 3297-301, 3302-4, 3313-4, 3326-47. PubMed ID: 16927402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexible two-stage design with sample size reassessment for survival trials.
    Desseaux K; Porcher R
    Stat Med; 2007 Nov; 26(27):5002-13. PubMed ID: 17577242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When was a "negative" clinical trial big enough? How many patients you needed depends on what you found.
    Detsky AS; Sackett DL
    Arch Intern Med; 1985 Apr; 145(4):709-12. PubMed ID: 3985731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in designing flexible trials.
    Posch M; Bauer P; Brannath W
    Stat Med; 2003 Mar; 22(6):953-69. PubMed ID: 12627412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials with allergen products--statistical considerations.
    Volkers P
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737
    [No Abstract]   [Full Text] [Related]  

  • 18. Sample size determination in clinical trials with an emphasis on exponentially distributed responses.
    Gross AJ; Hunt HH; Cantor AB; Clark BC
    Biometrics; 1987 Dec; 43(4):875-83. PubMed ID: 3427172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consultants' forum: should post hoc sample size calculations be done?
    Walters SJ
    Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Objective and perspective determine the choice of composite endpoint.
    Borm GF; Teerenstra S; Zielhuis GA
    J Clin Epidemiol; 2008 Feb; 61(2):99-101. PubMed ID: 18177781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.